| 1 |
Bayley JP, Devilee P. The Warburg effect in 2012[J]. Curr Opin Oncol,2012,24(1): 62-67.
|
| 2 |
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg Effect: the metabolic requirements of cell proliferation[J].Science, 2009,324(5930):1029-1033.
|
| 3 |
Augoff K, Hryniewicz-Jankowska A, Tabola R. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer[J]. Cancer Lett,2015,358(1):1-7.
|
| 4 |
Yu Y, Deck JA, Hunsaker LA, et al. Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4[J]. Biochem Pharmacol, 2001,62(1):81-89.
|
| 5 |
Granchi C, Bertini S, Macchia M, et al. Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials[J]. Curr Med Chem, 2010,17(7):672-697.
|
| 6 |
Musick WD, Rossmann MG. The structure of mouse testicular lactate dehydrogenase isoenzyme C4 at 2.9A resolution[J]. J Biol Chem,1979,254(16):7611-7620.
|
| 7 |
Gupta GS. LDH-C4: a target with therapeutic potential for cancer and contraception[J]. Mol Cell Biochem, 2012,371 (1-2):115-127.
|
| 8 |
Goldberg E, Eddy EM, Duan C, et al., LDHC: the ultimate testisspecific gene[J]. J Androl, 2010,31(1):86-94.
|
| 9 |
Short ML, Huang D, Milkowski DM, et al. Analysis of the rat lactate dehydrogenase A subunit gene promoter/regulatory region[J]. Biochem J, 1994,304 (Pt 2):391-398.
|
| 10 |
Shim H, Dolde C, Lewis BC, et al. c-Myc transactivation of LDH-A:implications for tumor metabolism and growth[J]. Proc Natl Acad Sci U S A, 1997,94(13):6658-6663.
|
| 11 |
Semenza GL, Jiang BH, Leung SW, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1[J]. J Biol Chem, 1996,271(51):32529-32537.
|
| 12 |
Koslowski M, Tureci O, Bell C, et al. Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer[J].Cancer Res, 2002,62(22): 6750-6755.
|
| 13 |
Sheng SL, Liu JJ, Dai YH, et al. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma[J]. FEBS J, 2012,279 (20):3898-3910.
|
| 14 |
Fan J, Hitosugi T, Chung TW, et al. Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells[J]. Mol Cell Biol, 2011,31 (24):4938-4950.
|
| 15 |
Zhao D, Xiong Y, Lei QY, et al. LDH-A acetylation: implication in cancer, Oncotarget[J]. 2013,4 (6):802-803.
|
| 16 |
Bouafia F, Drai J, Bienvenu J, et al. Profiles and prognostic values of serum LDH isoenzymes in patients with haematopoietic malignancies[J]. Bull Cancer, 2004,91 (7-8): E229-E240.
|
| 17 |
Ferraris AM, Giuntini P, Gaetani GF. Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas[J]. Blood, 1979,54(4):928-932.
|
| 18 |
García R, Hernández JM, Caballero MD, et al. Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease[J]. Br J Cancer, 1993,68 (6):1227-1231.
|
| 19 |
Gkotzamanidou M, Kastritis E, Gavriatopoulou MR, et al. Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma[J]. Clin. Lymphoma Myeloma Leuk, 2011,11(5):409-413.
|
| 20 |
Hermes A, Gatzemeier U, Waschki B, et al. Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer-a retrospective single institution analysis[J]. Respir Med,2010,104 (12):1937-1942.
|
| 21 |
Scartozzi M, Faloppi L, Bianconi M, et al. The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management[J]. PLoS One, 2012,7(3):e32653.
|
| 22 |
Faloppi L, Scartozzi M, Bianconi M, et al. The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management[J]. BMC Cancer,2014,14:110.
|
| 23 |
Jin Y, Ye X, Shao L, et al. Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy[J]. Eur J Cancer, 2013,49 (7):1619-1626.
|
| 24 |
Lu R, Jiang M, Chen Z, et al. Lactate dehydrogenase 5 expression in non-Hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis[J]. PLoS One, 2013,8 (9):e74853.
|
| 25 |
Scartozzi M, Giampieri R, Maccaroni E, et al. Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumabbased therapy in metastatic colorectal cancer patients[J]. Br J Cancer,2012,106 (5):799-804.
|
| 26 |
Yin C, Jiang C, Liao F, et al. Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer[J]. Onco Targets Ther, 2014,7:1415-1422.
|
| 27 |
Kolev Y, Uetake H, Takagi Y, et al. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxiainducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis[J]. Ann Surg Oncol, 2008,15 (8):2336-2344.
|
| 28 |
Nishitani K, Namba M, Kimoto T. Lactate dehydrogenase isozyme patterns of normal human fibroblasts and their in vitro-transformed counterparts obtained by treatment with CO-60 gamma-rays, SV40 or 4-nitroquinoline 1-oxide[J]. Gann, 1981,72 (2):300-304.
|
| 29 |
Carda-Abella P, Perez-Cuadrado S, Lara-Baruque S, et al. LDH isoenzyme patterns in tumors, polyps, and uninvolved mucosa of human cancerous colon[J]. Cancer, 1982,49 (1):80-83.
|
| 30 |
Lewis B, Morson BC, February AW, et al. Abnormal lactic dehydrogenase isoenzyme patterns in ulcerative colitis with precancerous change[J]. Gut, 1971,12 (1):16-19.
|
| 31 |
Mate J, Pajares JM, Moreno-Otero R, et al. Abnormal lactic dehydrogenase patterns in carcinoma of stomach and in peritumoral tissues[J]. Digestion, 1978,17 (5):377-382.
|
| 32 |
Doherty JR, Cleveland JL. Targeting lactate metabolism for cancer therapeutics[J]. J Clin Invest, 2013,123(9):3685-3692.
|
| 33 |
Wang ZY, Loo TY, Shen JG, et al. LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis[J]. Breast Cancer Res Treat,2012,131 (3):791-800.
|
| 34 |
Rong Y, Wu W, Ni X, et al. Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells[J]. Tumour Biol, 2013,34 (3):1523-1530.
|
| 35 |
Rizwan A, Serganova I, Khanin R, et al. Relationships between LDH-A, lactate, and metastases in 4T1 breast tumors[J]. Clin. Cancer Res, 2013,19 (18):5158-5169.
|
| 36 |
Kayser G, Kassem A, Sienel W, et al. Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1[J]. Diagn Pathol,2010,5:22.
|
| 37 |
Kim HS, Lee HE, Yang HK, et al. High lactate dehydrogenase 5 expression correlates with high tumoral and stromal vascular endothelial growth factor expression in gastric cancer[J]. Pathobiology,2013,81 (2):78-85.
|
| 38 |
Yao F, Zhao T, Zhong C, et al. LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma[J]. Tumour Biol, 2013,34 (1):25-31.
|
| 39 |
Grimm M, Alexander D, Munz A, et al. Increased LDH5 expression is associated with lymph node metastasis and outcome in oral squamous cell carcinoma[J]. Clin Exp Metastasis, 2013,30 (4):529-540.
|
| 40 |
Nishikawa A, Tanaka T, Takeuchi T, et al. The diagnostic significance of lactate dehydrogenase isoenzymes in urinary cytology[J]. Br J Cancer, 1991,63 (5):819-821.
|
| 41 |
von Eyben FE. A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors[J]. Clin Biochem, 2001,34 (6):441-454.
|